DLH HOLDINGS CORP (DLHC) Stock Fundamental Analysis
USA - NASDAQ:DLHC - US23335Q1004 - Common Stock
5.6 USD
+0.04 (+0.72%)
DLHC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. DLHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DLHC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DLHC was profitable.
DLHC had a positive operating cash flow in the past year.
Each year in the past 5 years DLHC has been profitable.
DLHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 1.53%, DLHC perfoms like the industry average, outperforming 43.90% of the companies in the same industry.
The Return On Equity of DLHC (4.03%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 6.51%, DLHC perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
DLHC had an Average Return On Invested Capital over the past 3 years of 11.89%. This is in line with the industry average of 13.40%.
The 3 year average ROIC (11.89%) for DLHC is well above the current ROIC(6.51%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.53% | ||
| ROE | 4.03% | ||
| ROIC | 6.51% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
1.3 Margins
Looking at the Profit Margin, with a value of 1.27%, DLHC is in line with its industry, outperforming 43.90% of the companies in the same industry.
DLHC's Profit Margin has declined in the last couple of years.
DLHC's Operating Margin of 5.81% is in line compared to the rest of the industry. DLHC outperforms 52.44% of its industry peers.
In the last couple of years the Operating Margin of DLHC has declined.
With a Gross Margin value of 19.88%, DLHC is not doing good in the industry: 76.83% of the companies in the same industry are doing better.
DLHC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.81% | ||
| PM (TTM) | 1.27% | ||
| GM | 19.88% |
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
DLHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DLHC has more shares outstanding
The number of shares outstanding for DLHC has been increased compared to 5 years ago.
DLHC has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.76, we must say that DLHC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DLHC (1.76) is worse than 70.73% of its industry peers.
The Debt to FCF ratio of DLHC is 5.74, which is a neutral value as it means it would take DLHC, 5.74 years of fcf income to pay off all of its debts.
DLHC has a Debt to FCF ratio (5.74) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.09 is on the high side and indicates that DLHC has dependencies on debt financing.
DLHC's Debt to Equity ratio of 1.09 is on the low side compared to the rest of the industry. DLHC is outperformed by 71.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.09 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.68
WACC9.59%
2.3 Liquidity
DLHC has a Current Ratio of 1.08. This is a normal value and indicates that DLHC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DLHC (1.08) is worse than 70.73% of its industry peers.
A Quick Ratio of 1.08 indicates that DLHC should not have too much problems paying its short term obligations.
DLHC has a Quick ratio of 1.08. This is in the lower half of the industry: DLHC underperforms 70.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The earnings per share for DLHC have decreased strongly by -37.25% in the last year.
The Earnings Per Share has been growing slightly by 1.22% on average over the past years.
Looking at the last year, DLHC shows a very negative growth in Revenue. The Revenue has decreased by -10.30% in the last year.
The Revenue has been growing by 19.81% on average over the past years. This is quite good.
EPS 1Y (TTM)-37.25%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-75%
Revenue 1Y (TTM)-10.3%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-17.23%
3.2 Future
Based on estimates for the next years, DLHC will show a very negative growth in Earnings Per Share. The EPS will decrease by -59.37% on average per year.
Based on estimates for the next years, DLHC will show a very negative growth in Revenue. The Revenue will decrease by -21.79% on average per year.
EPS Next Y-66%
EPS Next 2Y-59.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.41%
Revenue Next 2Y-21.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DLHC is valuated rather expensively with a Price/Earnings ratio of 17.50.
DLHC's Price/Earnings ratio is a bit cheaper when compared to the industry. DLHC is cheaper than 64.63% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.34. DLHC is valued slightly cheaper when compared to this.
The Forward Price/Earnings Ratio is negative for DLHC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DLHC is valued cheaper than 95.12% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DLHC is valued cheaply inside the industry as 98.78% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.34 | ||
| EV/EBITDA | 5.78 |
4.3 Compensation for Growth
DLHC's earnings are expected to decrease with -59.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)14.35
EPS Next 2Y-59.37%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for DLHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DLHC (10/14/2025, 1:22:38 PM)
5.6
+0.04 (+0.72%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners67.83%
Inst Owner Change0%
Ins Owners13.55%
Ins Owner Change1.32%
Market Cap80.58M
Analysts82.86
Price Target10.2 (82.14%)
Short Float %0.79%
Short Ratio3.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.96%
Min EPS beat(2)-15.97%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)9.18%
Min EPS beat(4)-15.97%
Max EPS beat(4)42.6%
EPS beat(8)4
Avg EPS beat(8)3.31%
EPS beat(12)6
Avg EPS beat(12)0.33%
EPS beat(16)8
Avg EPS beat(16)2.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.82%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-4.76%
Min Revenue beat(4)-8.25%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-3.95%
Revenue beat(12)1
Avg Revenue beat(12)-4.15%
Revenue beat(16)3
Avg Revenue beat(16)-2.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.5 | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | 3.34 | ||
| P/OCF | 3.28 | ||
| P/B | 0.71 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.78 |
EPS(TTM)0.32
EY5.71%
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)1.68
FCFY29.92%
OCF(TTM)1.71
OCFY30.45%
SpS25
BVpS7.9
TBVpS-8.37
PEG (NY)N/A
PEG (5Y)14.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.53% | ||
| ROE | 4.03% | ||
| ROCE | 8.24% | ||
| ROIC | 6.51% | ||
| ROICexc | 6.51% | ||
| ROICexgc | 86.01% | ||
| OM | 5.81% | ||
| PM (TTM) | 1.27% | ||
| GM | 19.88% | ||
| FCFM | 6.7% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
ROICexc(3y)11.91%
ROICexc(5y)11.55%
ROICexgc(3y)142.07%
ROICexgc(5y)N/A
ROCE(3y)15.05%
ROCE(5y)13.95%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-9.4%
ROICexc growth 3Y-17.74%
ROICexc growth 5Y-3.87%
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.09 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 3.29 | ||
| Cap/Depr | 2.51% | ||
| Cap/Sales | 0.12% | ||
| Interest Coverage | 1.45 | ||
| Cash Conversion | 64.97% | ||
| Profit Quality | 526.26% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 1.76 |
F-Score7
WACC9.59%
ROIC/WACC0.68
Cap/Depr(3y)6.77%
Cap/Depr(5y)4.74%
Cap/Sales(3y)0.2%
Cap/Sales(5y)0.14%
Profit Quality(3y)813.86%
Profit Quality(5y)632.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-37.25%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-75%
EPS Next Y-66%
EPS Next 2Y-59.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.3%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-17.23%
Revenue Next Year-13.41%
Revenue Next 2Y-21.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.78%
EBIT growth 3Y10.79%
EBIT growth 5Y16.91%
EBIT Next Year43.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.84%
FCF growth 3Y-16.5%
FCF growth 5Y8.52%
OCF growth 1Y16.84%
OCF growth 3Y-15.69%
OCF growth 5Y8.69%